Open AccessBioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions
Author(s) -
Qiuying Li,
Lihui Jia,
Junliang Yuan,
Shu Dong,
Chaohong Cai
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s304108
Subject(s) - bioequivalence , tenofovir alafenamide , medicine , cmax , pharmacokinetics , confidence interval , crossover study , adverse effect , randomized controlled trial , clinical trial , pharmacology , human immunodeficiency virus (hiv) , placebo , viral load , immunology , alternative medicine , pathology , antiretroviral therapy
To evaluate the bioequivalence and safety of two formulations of 25 mg tenofovir alafenamide tablets in Chinese healthy male and female subjects under fed and fasting conditions.